Anti-TNF Therapy Appears Safe in Patients With Hepatitis C and Inflammatory Bowel Disease: Presented at ACG

No immediate signals of adverse problems were observed among patients with hepatitis C virus (HCV) infection and inflammatory bowel disease (IBD) who were administered infliximab, researchers said here at the American College of Gastroenterology (ACG) 75th Annual Scientific Meeting.